Doctor profile · Federal record

Dr. Celeste Wilcox, MD, PHD

Medical Oncology Physician (CMS: Medical Oncology) · Paris, TX

  • NPI 1386688232
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 31 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3550 Ne Loop 286
Paris, TX 754605004
(903) 785-0031
fax (903) 784-6755
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
March 7, 2016
Year of graduation
1995 — 31 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #K0571
Medicaid (4)
OK #200032050A · TX #156005402 · TX #156005401 · TX #156005403

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1386688232. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
207,951
Distinct HCPCS
10
Medicare allowed
$2,124,383
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 66,300 68 $0
J1453 Injection, fosaprepitant, 1 mg 23,700 59 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 21,159 27 $3
J9271 Injection, pembrolizumab, 1 mg 18,800 28 $53
J9263 Injection, oxaliplatin, 0.5 mg 14,750 19 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 12,084 106 $0
J9267 Injection, paclitaxel, 1 mg 10,711 23 $0
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 6,510 16 $42
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,188 137 $0
J0897 Injection, denosumab, 1 mg 3,960 41 $23

In context: peer comparison

Among 3 peers in this city , average services per provider: 2,374. This provider delivers 88× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$68
Transactions
4
Manufacturers
4
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 1 $19.18
Daiichi Sankyo Inc. 1 $17.88
Takeda Pharmaceuticals U.S.A., Inc. 1 $16.40
Novartis Pharmaceuticals Corporation 1 $14.14

By nature of payment

Food and Beverage
$51
Education
$16

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
648
Patients
133
Total drug cost
$365,366
Drug Type Claims Patients Total cost
Anastrozole Generic 120 28 $2,494
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 106 37 $2,369
Potassium Chloride Generic 49 18 $2,860
Acyclovir Generic 44 0 $515
Letrozole Generic 40 11 $720
Dexamethasone Generic 39 15 $717
Duloxetine Hcl Generic 39 11 $1,120
Prednisone Generic 35 13 $259
Hydroxyurea Generic 34 0 $1,283
Eliquis (Apixaban) Brand 33 0 $23,745

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Celeste Wilcox's medical specialty?
Dr. Celeste Wilcox practices Medical Oncology Physician in Paris, TX.
Where does Dr. Celeste Wilcox practice?
Dr. Celeste Wilcox practices at 3550 Ne Loop 286, Paris, TX 754605004. Office phone: 9037850031.
What is Dr. Celeste Wilcox's NPI?
Dr. Celeste Wilcox's National Provider Identifier (NPI) is 1386688232, issued by NPPES.
Does Dr. Celeste Wilcox accept Medicare assignment?
Yes. Dr. Celeste Wilcox accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Celeste Wilcox commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.